Lv31
320 积分 2022-03-04 加入
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disorders
4小时前
已完结
Brain Penetrant NLRP3 Inhibitors: The Discovery of a Panacea?
4小时前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
4小时前
已完结
Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
4小时前
已完结
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
5天前
已完结
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
7天前
已完结
Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans
18天前
已完结
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
18天前
已完结
BPS2025 - All roads lead to Rome: Class B1 GPCRs show distinct activation mechanisms, but similar active states
24天前
已完结
BPS2025 - All roads lead to Rome: Class B1 GPCRs show distinct activation mechanisms, but similar active states
1个月前
已完结
皖公网安备34019202002308
